Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases
Conditions: Breast Cancer With Brain Metastases Interventions: Drug: pyrotinib+capecitabine+bevacizumab Sponsors: Tongji Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Hospitals | Neurology | Research | Xeloda